Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema

João Tadeu Ribeiro-Paes1, Aldemir Bilaqui2, Oswaldo T Greco2, Milton Artur Ruiz2, Monica Y Marcelino3, Talita Stessuk1, Carolina A de Faria3, Mario R Lago21Universidade Estadual Paulista (UNESP), Campus de Assis, Assis, SP, Brazil; 2Cardiovascular Diseases Institute (IMC), S&a...

Full description

Bibliographic Details
Main Authors: João Tadeu Ribeiro-Paes, Aldemir Bilaqui, Oswaldo T Greco, et al
Format: Article
Language:English
Published: Dove Medical Press 2011-01-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/unicentric-study-of-cell-therapy-in-chronic-obstructive-pulmonary-dise-a6046
_version_ 1811244266990600192
author João Tadeu Ribeiro-Paes
Aldemir Bilaqui
Oswaldo T Greco
et al
author_facet João Tadeu Ribeiro-Paes
Aldemir Bilaqui
Oswaldo T Greco
et al
author_sort João Tadeu Ribeiro-Paes
collection DOAJ
description João Tadeu Ribeiro-Paes1, Aldemir Bilaqui2, Oswaldo T Greco2, Milton Artur Ruiz2, Monica Y Marcelino3, Talita Stessuk1, Carolina A de Faria3, Mario R Lago21Universidade Estadual Paulista (UNESP), Campus de Assis, Assis, SP, Brazil; 2Cardiovascular Diseases Institute (IMC), São José do Rio Preto, SP, Brazil; 3Inter-units Biotechnology Post Graduation Program, USP-IPT-I, Butantan, São Paulo, SP, BrazilAbstract: Within the chronic obstructive pulmonary disease (COPD) spectrum, lung emphysema presents, as a primarily histopathologic feature, the destruction of pulmonary parenchyma and, accordingly, an increase in the airflow obstruction distal to the terminal bronchiole. Notwithstanding the significant advances in prevention and treatment of symptoms, no effective or curative therapy has been accomplished. In this context, cellular therapy with stem cells (SCs) arises as a new therapeutic approach, with a wide application potential. The purpose of this study is to evaluate the safety of SCs infusion procedure in patients with advanced COPD (stage IV dyspnea). After selection, patients underwent clinical examination and received granulocyte colony-stimulating factor, immediately prior to the bone marrow harvest. The bone marrow mononuclear cells (BMMC) were isolated and infused into a peripheral vein. The 12-month follow-up showed a significant improvement in the quality of life, as well as a clinical stable condition, which suggest a change in the natural process of the disease. Therefore, the proposed methodology in this study for BMMC cell therapy in sufferers of advanced COPD was demonstrated to be free of significant adverse effects. Although a larger sample and a greater follow-up period are needed, it is possible to infer that BMMC cell therapy introduces an unprecedented change in the course or in the natural history of emphysema, inhibiting or slowing the progression of disease. This clinical trial was registered with ClinicalTrials.gov (NCT01110252) and was approved by the Brazilian National Committee of Ethics in Research (registration no. 14764, CONEP report 233/2009).Keywords: cell therapy, chronic obstructive pulmonary disease COPD, pulmonary emphysema, BMMC, stem cells
first_indexed 2024-04-12T14:22:59Z
format Article
id doaj.art-5859bd81ffd74f1895de8d8d9cd1a1f2
institution Directory Open Access Journal
issn 1176-9106
1178-2005
language English
last_indexed 2024-04-12T14:22:59Z
publishDate 2011-01-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-5859bd81ffd74f1895de8d8d9cd1a1f22022-12-22T03:29:31ZengDove Medical PressInternational Journal of COPD1176-91061178-20052011-01-012011default6371Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysemaJoão Tadeu Ribeiro-PaesAldemir BilaquiOswaldo T Grecoet alJoão Tadeu Ribeiro-Paes1, Aldemir Bilaqui2, Oswaldo T Greco2, Milton Artur Ruiz2, Monica Y Marcelino3, Talita Stessuk1, Carolina A de Faria3, Mario R Lago21Universidade Estadual Paulista (UNESP), Campus de Assis, Assis, SP, Brazil; 2Cardiovascular Diseases Institute (IMC), São José do Rio Preto, SP, Brazil; 3Inter-units Biotechnology Post Graduation Program, USP-IPT-I, Butantan, São Paulo, SP, BrazilAbstract: Within the chronic obstructive pulmonary disease (COPD) spectrum, lung emphysema presents, as a primarily histopathologic feature, the destruction of pulmonary parenchyma and, accordingly, an increase in the airflow obstruction distal to the terminal bronchiole. Notwithstanding the significant advances in prevention and treatment of symptoms, no effective or curative therapy has been accomplished. In this context, cellular therapy with stem cells (SCs) arises as a new therapeutic approach, with a wide application potential. The purpose of this study is to evaluate the safety of SCs infusion procedure in patients with advanced COPD (stage IV dyspnea). After selection, patients underwent clinical examination and received granulocyte colony-stimulating factor, immediately prior to the bone marrow harvest. The bone marrow mononuclear cells (BMMC) were isolated and infused into a peripheral vein. The 12-month follow-up showed a significant improvement in the quality of life, as well as a clinical stable condition, which suggest a change in the natural process of the disease. Therefore, the proposed methodology in this study for BMMC cell therapy in sufferers of advanced COPD was demonstrated to be free of significant adverse effects. Although a larger sample and a greater follow-up period are needed, it is possible to infer that BMMC cell therapy introduces an unprecedented change in the course or in the natural history of emphysema, inhibiting or slowing the progression of disease. This clinical trial was registered with ClinicalTrials.gov (NCT01110252) and was approved by the Brazilian National Committee of Ethics in Research (registration no. 14764, CONEP report 233/2009).Keywords: cell therapy, chronic obstructive pulmonary disease COPD, pulmonary emphysema, BMMC, stem cellshttp://www.dovepress.com/unicentric-study-of-cell-therapy-in-chronic-obstructive-pulmonary-dise-a6046
spellingShingle João Tadeu Ribeiro-Paes
Aldemir Bilaqui
Oswaldo T Greco
et al
Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
International Journal of COPD
title Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
title_full Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
title_fullStr Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
title_full_unstemmed Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
title_short Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
title_sort unicentric study of cell therapy in chronic obstructive pulmonary disease pulmonary emphysema
url http://www.dovepress.com/unicentric-study-of-cell-therapy-in-chronic-obstructive-pulmonary-dise-a6046
work_keys_str_mv AT joampatildeotadeuribeiropaes unicentricstudyofcelltherapyinchronicobstructivepulmonarydiseasepulmonaryemphysema
AT aldemirbilaqui unicentricstudyofcelltherapyinchronicobstructivepulmonarydiseasepulmonaryemphysema
AT oswaldotgreco unicentricstudyofcelltherapyinchronicobstructivepulmonarydiseasepulmonaryemphysema
AT etal unicentricstudyofcelltherapyinchronicobstructivepulmonarydiseasepulmonaryemphysema